Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2006; 12(47): 7613-7620
Published online Dec 21, 2006. doi: 10.3748/wjg.v12.i47.7613
Published online Dec 21, 2006. doi: 10.3748/wjg.v12.i47.7613
Figure 2 Selective oncolytic effect of SG300 on HCC cell lines.
At MOI = 10, the cell viability was < 30% in HCC cells, but > 68% in normal cells when infected with SG300. The oncolytic effect of SG300 was stronger on HCC cells and weaker on normal cells than that of ONYX-015, being close to that of WAd5. The killing effect of SG300 and ONYX-015 on normal cells became apparent when MOI = 100. —▲—SG300, —□—ONYX-015, —◆—WAd5.
- Citation: Su CQ, Wang XH, Chen J, Liu YJ, Wang WG, Li LF, Wu MC, Qian QJ. Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma. World J Gastroenterol 2006; 12(47): 7613-7620
- URL: https://www.wjgnet.com/1007-9327/full/v12/i47/7613.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i47.7613